Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury
Launched by UNIVERSITY OF MINNESOTA · May 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new type of therapy called remote cognitive multisensory rehabilitation (CMR) for adults with spinal cord injuries (SCI). The goal is to see if this therapy, which has shown promise when done in person, can also help patients recover their movement and sensory functions when delivered remotely. By participating in this trial, researchers hope to gather important information about how the brain can improve and how these changes might lead to better recovery for people with chronic spinal cord injuries.
To be eligible for the trial, participants should be between 18 and 75 years old and have had a spinal cord injury for at least three months. They should also be stable in their medical condition. Participants will be recruited from various hospitals and clinics in Minnesota and will be asked to follow specific instructions and complete tasks as part of the rehabilitation program. It’s important to note that certain individuals, such as those with severe cognitive issues or other major medical complications, may not qualify. Overall, this trial aims to provide valuable insights that could lead to larger studies and better treatment options for those living with spinal cord injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-75 years old, with an incomplete or complete SCI/D of ≥ 3months, medically stable.
- • be recruited from Hospitals within the Minnesota Regional Spinal Cord Injury Model System (MN Regional SCIMS), HealthPartners Neuroscience Center, Minneapolis VA Healthcare System, Duluth, and in the community.
- Exclusion Criteria:
- • adults with MRI contra-indications (stabilizing hardware is typically MRI safe);
- • adults with uncontrolled seizure disorder;
- • adults with cognitive impairment and/or communicative disability (e.g., due to brain injury) that prevent them from following directions or from learning;
- • adults with with ventilator dependency;
- • adults with other major medical complications
- • pregnant women
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported